Search results
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 4 days ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
WHTC 1450 Holland· 5 days agoTOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as...
Ventral subiculum promotes wakefulness through several pathways in male mice -...
Nature· 3 days agoThe ventral subiculum (vSUB), the major output structure of the hippocampal formation, regulates motivation, stress integration, and anxiety-like behaviors that rely on heightened arousal. However ...
Citigroup Lowers Axsome Therapeutics (NASDAQ:AXSM) Price Target to $125.00
ETF DAILY NEWS· 5 days agoAxsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective reduced by Citigroup from $127.00 to $125.00 in a research note issued to investors on Tuesday, Benzinga reports.
HC Wainwright Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
ETF DAILY NEWS· 5 days agoAxsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a report released on Tuesday, Benzinga reports. Robert W.
Leerink Partnrs Comments on Axsome Therapeutics, Inc.’s FY2026 Earnings (NASDAQ:AXSM)
ETF DAILY NEWS· 5 days agoAxsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at Leerink Partnrs reduced their FY2026 earnings per share estimates for shares of Axsome Therapeutics in a report released ...
Mizuho Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $106.00
ETF DAILY NEWS· 3 days agoAxsome Therapeutics (NASDAQ:AXSM – Free Report) had its price target decreased by Mizuho from $109.00 to $106.00 in a research note issued to investors on Wednesday, Benzinga reports. Mizuho ...